Wyeth urged to mend fences with Daewoong
Published: 2009-12-04 07:00:00
Updated: 2009-12-04 07:00:00
Wyeth Pharmaceuticals will have to seek a win-win game with Daewoong Pharm as their relations have turned sour since the stern refusal of Wyeth over the development of novel anti-infective agent, according to market observers.
So far, the two companies have maintained a closer relationship for...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
